FindTrial
Sign In

The effect and safety of 15mCi 131 I-iodine in treatment of children and adolescents with hyperthyroidism—a multicenter prospective study

Analysis of the effect of 15mCi 131 iodine in the treatment of children and adolescents with Graves disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051315
Enrollment
Unknown
Registered
2021-09-18
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children and Adolescents with Graves disease

Interventions

test group:No

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.Aged 35%; 4.The patient volunteered to participate in the study, and he or his legal guardian signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Thyroid enlargement of degree III and above, accompanied by compression symptoms (such as swallowing, difficulty breathing); 2. Combined with thyroid cancer; 3. Combined active proptosis.

Design outcomes

Primary

MeasureTime frame
thyroid function;thyroid volume;adverse events;thyroid uptake rate;—

Secondary

MeasureTime frame
routine blood test;electrocardiogram;—

Countries

China

Contacts

Public ContactLiu Bin

West China Hospital of Sichuan University

binl@foxmail.com+86 18980606827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026